Vanguard holds 5.27% of Dentsply Sirona common stock
DENTSPLY SIRONA Inc (Common Stock, CUSIP 24906P109) is reported in a Schedule 13G by Vanguard Capital Management.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
DENTSPLY SIRONA Inc (Common Stock, CUSIP 24906P109) is reported in a Schedule 13G by Vanguard Capital Management. The filing states Vanguard beneficially owns 10,529,427 shares, representing 5.27% of the class. The filer reports 1,529,870 shares of sole voting power and 10,529,427 shares of sole dispositive power. The filing lists Vanguard's Malvern, PA address and is signed by Ashley Grim, Head of Global Fund Administration, dated 04/29/2026.
Insights
Vanguard holds a >5% passive stake in Dentsply Sirona.
The Schedule 13G indicates an institutional, potentially passive holding of 10,529,427 shares (5.27%). The filing specifies sole voting power of 1,529,870 and sole dispositive power equal to the full share count, suggesting investment-advisory control over disposition.
Cash-flow treatment and intent (active vs passive) are not expanded in the excerpt; subsequent filings could clarify any change in intent.
Key Figures
Key Terms
Schedule 13G regulatory
Beneficially owned financial
Sole dispositive power regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake does Vanguard Capital Management report in DENTSPLY SIRONA (XRAY)?
Who signed the Schedule 13G for Vanguard on behalf of these holdings?
What is the CUSIP for DENTSPLY SIRONA common stock in this filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.